Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Expert Discusses How DMT Differs From Other Psychedelic Medicines
Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discusses DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.
Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discussed DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.
She spoke about the benefits of DMT, what the treatment targets are, and early research of the drug.
Related Videos
Related Content
